| __timestamp | GSK plc | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8246000000 | 72471000 |
| Thursday, January 1, 2015 | 9232000000 | 89204000 |
| Friday, January 1, 2016 | 9366000000 | 106010000 |
| Sunday, January 1, 2017 | 9672000000 | 137905000 |
| Monday, January 1, 2018 | 9915000000 | 159888000 |
| Tuesday, January 1, 2019 | 11402000000 | 158425000 |
| Wednesday, January 1, 2020 | 11456000000 | 200677000 |
| Friday, January 1, 2021 | 10975000000 | 304759000 |
| Saturday, January 1, 2022 | 8372000000 | 377221000 |
| Sunday, January 1, 2023 | 9385000000 | 336361000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, GSK plc and Supernus Pharmaceuticals, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, GSK's SG&A expenses fluctuated, peaking in 2020 with a 39% increase from 2014, before dropping by 27% in 2022. Meanwhile, Supernus Pharmaceuticals, Inc. demonstrated a steady upward trend, with a remarkable 364% increase in SG&A expenses over the same period.
GSK's strategy appears to focus on maintaining a balance, with expenses averaging around 9.8 billion annually. In contrast, Supernus Pharmaceuticals, Inc. has aggressively expanded, with expenses growing from 72 million in 2014 to 336 million in 2023. This divergence highlights the distinct strategic approaches of these companies in managing operational costs, reflecting their unique market positions and growth ambitions.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: GSK plc vs ADMA Biologics, Inc.
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Supernus Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.